Literature DB >> 17951358

Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.

F Zerbib1, A Duriez, S Roman, M Capdepont, F Mion.   

Abstract

BACKGROUND AND AIMS: Approximately 20% of patients have persistent symptoms of gastro-oesophageal reflux despite proton pump inhibitor (PPI) therapy. The aim of this study was to assess the determinants of reflux perception in patients on PPI therapy. PATIENTS AND METHODS: 20 patients with typical gastro-oesophageal reflux symptoms (heartburn and/or regurgitation) despite double-dose PPIs (twice daily) were included in this study. Ambulatory 24 h pH-impedance studies were performed in all patients. The characteristics of symptomatic and asymptomatic reflux episodes were compared. Symptoms were considered globally and separately for heartburn and regurgitation.
RESULTS: A total of 1273 reflux episodes were detected including 243 (19.1%) acidic, 1018 (80.0%) weakly acidic and 12 (0.9%) weakly alkaline reflux episodes. Overall, 312 (24.5%) reflux episodes were symptomatic. The only factor associated with reflux perception was high proximal extent (p = 0.037). Compared with regurgitation, reflux episodes associated with heartburn were more frequently pure liquid (p = 0.009) and acidic (p = 0.027), had a lower nadir pH (p<0.001), were more frequently preceded by acid reflux episodes (p<0.001) and had a longer reflux bolus clearance time (p<0.001).
CONCLUSIONS: High proximal extent of the refluxate is the only factor associated with reflux perception in patients on double-dose PPI. However, compared with regurgitation, composition of the refluxate, sensitisation of the oesophagus by preceding acid exposure and delayed bolus clearance appear to play a role in heartburn perception.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17951358     DOI: 10.1136/gut.2007.133470

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  36 in total

1.  Treatment of Refractory Gastroesophageal Reflux Disease.

Authors:  Rishi D Naik; Matthew H Meyers; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-04

2.  When proton pump inhibitors fail.

Authors:  Peter J Kahrilas
Journal:  Clin Gastroenterol Hepatol       Date:  2008-04-18       Impact factor: 11.382

3.  Airway reflux, cough and respiratory disease.

Authors:  Ian D Molyneux; Alyn H Morice
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

4.  Alginates: From the ocean to gastroesophageal reflux disease treatment.

Authors:  Serhat Bor; İsmail Hakkı Kalkan; Altay Çelebi; Dinç Dinçer; Filiz Akyüz; Peter Dettmar; Hasan Özen
Journal:  Turk J Gastroenterol       Date:  2019-09       Impact factor: 1.852

5.  Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring.

Authors:  Marzio Frazzoni; Rita Conigliaro; Gianluigi Melotti
Journal:  Dig Dis Sci       Date:  2010-08-25       Impact factor: 3.199

6.  Characteristics of symptomatic reflux episodes in Japanese proton pump inhibitor-refractory non-erosive reflux disease patients.

Authors:  Kenichiro Nakagawa; Tomoyuki Koike; Katsunori Iijima; Masahiro Saito; Hiroki Kikuchi; Waku Hatta; Nobuyuki Ara; Kaname Uno; Naoki Asano; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

7.  Long-term results of electrical stimulation of the lower esophageal sphincter for treatment of proximal GERD.

Authors:  Toshitaka Hoppo; Leonardo Rodríguez; Edy Soffer; Michael D Crowell; Blair A Jobe
Journal:  Surg Endosc       Date:  2014-07-22       Impact factor: 4.584

8.  The role of weakly acidic reflux in proton pump inhibitor failure, has dust settled?

Authors:  Emmanouela Tsoukali; Daniel Sifrim
Journal:  J Neurogastroenterol Motil       Date:  2010-07-27       Impact factor: 4.924

9.  Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux.

Authors:  S Roman; L Keefer; H Imam; P Korrapati; B Mogni; K Eident; L Friesen; P J Kahrilas; Z Martinovich; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2015-09-04       Impact factor: 3.598

10.  Gastroesophageal reflux disease: medical or surgical treatment?

Authors:  Theodore Liakakos; George Karamanolis; Paul Patapis; Evangelos P Misiakos
Journal:  Gastroenterol Res Pract       Date:  2009-12-31       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.